title: Managing gout: how is it different in patients with chronic kidney disease?
abstract: Many patients with gout have comorbidities, including hypertension and chronic kidney disease (CKD). The goals when treating gout are no different in these patients, but the choice and dosage of drugs may need to be modified.
authors.affiliation: Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Weston, FL, USA.
authors.forename: Hossam
authors.initials: H
authors.lastname: El-Zawawy
authors.forename: Brian F
authors.initials: BF
authors.lastname: Mandell
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000009:adverse effects / Q000627:therapeutic use; D000493:Allopurinol / Q000009:adverse effects* / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D003078:Colchicine / Q000009:adverse effects / Q000627:therapeutic use; D015897:Comorbidity; D018450:Disease Progression; D000069465:Febuxostat; D006073:Gout / Q000188:drug therapy*; D006074:Gout Suppressants / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000473:pathology*; D012307:Risk Factors; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006074:Gout Suppressants; D013844:Thiazoles; D000069465:Febuxostat; D000493:Allopurinol; D000324:Adrenocorticotropic Hormone; D003078:Colchicine